Biotech finally showed some signs of a rebound in trading ThursdayThe SPDR Biotech ETF (XBI) rose nearly 4% on the day, its second similar-sized rally over the past two weeksThe rebound is welcomedLife has not been easy for the small-cap biotech investor so far in 2021. The sector got out of the gate well in January but has vastly underperformed t...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.